US 8785373
Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer treatment
granted A61KA61K2039/505A61K38/1709
Quick answer
US patent 8785373 (Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer treatment) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
- Grant date
- Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2039/505, A61K38/1709, A61P, A61P13/08